Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-human MSLN monoclonal antibody and application thereof

A monoclonal antibody and antigen technology, applied in applications, antibodies, anti-animal/human immunoglobulins, etc., can solve the problem that the antibody screening scheme has not been publicly reported, save development time and cost, shorten the screening process, High affinity effect

Active Publication Date: 2020-06-30
NANJING BLUE SHIELD BIOTECH CO LTD
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As far as antibodies targeting MSLN are concerned, there are no public reports on the development of fully human ScFv antibodies, and there are no public reports on the screening of antibodies targeting MSLN based on phage display technology.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human MSLN monoclonal antibody and application thereof
  • Anti-human MSLN monoclonal antibody and application thereof
  • Anti-human MSLN monoclonal antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] Below in conjunction with specific example, further illustrate the present invention.

[0031] (1) Phage display antibody library panning

[0032] 1) Host TG1 activation: Prepare mini agar medium plate [1×M9 salt, 2% glucose, 2mM MgSO 4 , 0.1mM CaCl 2 , 1mM vitamin B1], streak overnight culture TG1 in a 37 ℃ incubator.

[0033]2) Coating: Dilute human MSLN protein (purchased from Acro Biosystem) in 0.1M NaHCO at a concentration of 50ug / ml 3 (pH8.6), take 1.5ml into the immunotube, and coat overnight at 4°C. After removing the coating solution, incubate with blocking solution [0.01M PBS buffer (pH7.4), 2% skimmed milk powder] for 1 hour, and wash 4 times with 0.01M PBS buffer (pH7.4) after the end.

[0034] 3) Combine: take 10 11 Add pfu phage virus particles to 1.5ml MPBS solution [0.01MPBS buffer (pH7.4), 2% skimmed milk powder] in the immunotube, and incubate at room temperature for 1 hour. After removing the liquid, wash 8 times with PBST solution [0.01M PBS bu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an anti-human MSLN monoclonal antibody and an application thereof, and is a specific and high-affinity single-chain antibody developed by taking human MSLN as a target based ona phage display technology. Compared with the prior art, the anti-human MSLN monoclonal antibody is successfully prepared, the antibody is good in specificity and high in affinity and can be combinedwith human MSLN expressed on the surface of a cell, and the anti-human MSLN monoclonal antibody is a potential drug for tumor treatment.

Description

technical field [0001] The invention belongs to the technical field of monoclonal antibodies, in particular to an anti-human MSLN monoclonal antibody and its application. Background technique [0002] Mesothelin (MSLN) is a 40KD glycoprotein located on the cell surface, which is anchored to the cell membrane by glycosylphosphatidylinositol. The mesothelin gene encodes a 69kDa precursor protein, which is hydrolyzed into two chains by furin (paired basic amino acid protease, furin)-like invertase, and the membrane-bound protein of about 40KD at the C-terminal is the mature mesothelial protein The N-terminal 30KD fragment called megakaryocyte-promoting factor (MPF) falls off and is released outside the cell. Both MPF and membrane anchor MSLN are N-glycosylated, MPF can promote the formation of megakaryocyte clones in vitro, membrane anchor MSLN can interact with MUC16, and plays an important role in the process of cell adhesion, so currently targeted therapy is Membrane-ancho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/30C12N15/13G01N33/574A61K39/395A61P35/00
CPCA61P35/00C07K16/005C07K16/30C07K2317/24C07K2317/92G01N33/57484
Inventor 张军锋郭志刚
Owner NANJING BLUE SHIELD BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com